Skip to main content
Caplight Logo









Netholabs

Netholabs

Private
LondonHealthcare & Life Scienceshttps://netholabs.com/

Last Round

Seed

Mar 10, 2025

Company Overview

Netholabs operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2025.

Netholabs is a biotechnology and AI company that develops neuroscience research tools designed to study whole-brain functional dynamics and behavior through large-scale experimental data generation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical AI, Synthetic Data

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service, Services & Consulting, Government Contracts

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Netholabs Comparables

Compare Netholabs with similar companies based on industry and business-model similarity.

Netholabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eon Systems
77%
Deuteron Technologies
69%
SpikeGadgets
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Netholabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 10, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Netholabs Investors

Notable investors and investment history

Netholabs investors
InvestorRounds
Leo LionSeed
Generative VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2025

    Seed round raised with participation from Generative Ventures and Catalyze AI.

Book a demo to see all signals

For institutional investors. Book with your work email.

Netholabs Filings

Explore SEC and related filing metadata, where available.

Netholabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Netholabs's valuation, stock price, and market status.

Is Netholabs a public or private company?

Netholabs is a private company.

What is the current stock price of Netholabs?

Netholabs is a private company, so its shares have no public market price. Caplight tracks Netholabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Netholabs worth (valuation)?

Valuation information for Netholabs is not publicly available.

Can I buy Netholabs stock?

Netholabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Netholabs's last funding round?

Netholabs's most recent funding round was Seed on March 10, 2025.

Who are the main investors in Netholabs?

Key investors in Netholabs include Leo Lion, Generative Ventures.

Will Netholabs IPO soon?

No public IPO plans have been announced for Netholabs.

How can I track Netholabs secondary market activity?

Caplight tracks bids, offers, and trades in Netholabs's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Year Founded2024
Last FundingMar 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?